Board Meeting Intimation for Consider And Approve Draft Scheme Of Amalgamation Of Lincoln Parenteral Limited ('The Transferor Company') With Lincoln Pharmaceuticals Limited ('The Transferee Company').

• Security Code: 531633
• Company: LINCOLN

LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/09/2019 ,inter alia, to consider and approve Draft scheme of amalgamation of Lincoln Parenteral Limited ('The Transferor Company') with Lincoln Pharmaceuticals Limited ('The Transferee Company') and Any other businesses with the permission of the Board.